CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
CD34+ stem cell selection in children, adolescents and young adults receiving partially
matched family donor or matched unrelated adult donor allogeneic bone marrow or peripheral
blood stem cell transplant will be safe and well tolerated and be associated with a low
incidence of serious (Grade III/IV) acute and chronic graft versus host disease (GVHD).